Educo Life Sciences

Discover our comprehensive portfolio of pharmaceutical training courses, featuring key topics such as regulatory affairs, CMC, manufacturing, development, and operations. Whether you are involved in R&D, formulation, quality assurance, regulatory affairs, or operational functions, we provide training courses that seamlessly connect theory with practical application across international markets.

Our pharmaceutical regulatory affairs training courses encompass all aspects of regulatory frameworks (EMA, FDA, ICH), including CTD dossier preparation, marketing authorisation applications, variations, and lifecycle management. Whether you are just beginning your career or looking to enhance your expertise, our courses provide invaluable practical insights to ensure compliance in global markets.

Enhance your understanding and expertise in biotechnology with our extensive Biotechnology Training Courses. Covering areas such as biotech development, cell culture, bioprocessing, downstream purification, and quality control, our programmes effectively connect scientific theory with practical industrial applications for biotechnology professionals.

Enhance your expertise in Cell & Gene Therapy (CGT) and Advanced Therapy Medicinal Products (ATMPs) with our specialised training programmes. Covering key areas from CMC and manufacturing to regulatory strategy and early development, our courses empower professionals to take the lead in this rapidly advancing sector.

Discover our extensive range of CMC & manufacturing training courses, featuring comprehensive topics such as analytical method development and validation, technology transfer, process scale-up, and regulatory requirements for pharmaceuticals, biologics, and advanced therapies. Enhance your expertise and stay abreast of industry standards with our expertly designed programmes.

Whether your organisation is beginning its AI journey or looking to scale AI adoption, we design bespoke training programmes around your objectives. From AI awareness through to practical implementation, governance, validation and regulatory compliance, our experts help teams confidently adopt AI across research, development, manufacturing, quality, regulatory affairs and medical devices

Explore our portfolio of AI training courses designed specifically for professionals working in pharmaceuticals, biotechnology, cell and gene therapy, CMC, regulatory affairs, quality, manufacturing and medical devices. Learn how Artificial Intelligence and Generative AI are transforming life sciences whilst understanding practical applications, regulatory expectations and implementation strategies.

Discover our extensive range of medical device training courses, including EU MDR, IVDR, ISO 13485, risk management, clinical evidence, and global compliance. Led by industry experts, our programmes are designed to assist you in successfully navigating device development and regulations around the world.

Our medical device regulatory affairs training courses encompass a comprehensive range of topics, including regulatory frameworks (MDR, FDA, ISO Standards), combination products, labelling, artificial intelligence, and so much more. Whether you are just beginning your career or looking to enhance your skills, our courses provide essential practical insights for ensuring compliance of medical devices and in-vitro diagnostics (IVDs) in global markets.

Discover how to comply with the latest regulatory standards and gather the appropriate type and volume of evidence. Delve into the complete clinical evaluation process, clinical investigations, and post-market clinical follow-up (PMCF). You will also examine essential clinical documents such as the Clinical Investigation Plan (CIP), Clinical Investigation Report (CIR), Clinical Evaluation Plan (CEP), Clinical Evaluation Report (CER), Clinical Development Plan (CDP), Summary of Safety and Clinical Performance (SSCP), and PMCF plans and reports.

Discover our comprehensive range of IVD training courses that encompass EU IVDR, ISO 13485, risk management, clinical performance, and global compliance. Delivered by seasoned industry experts, our programmes are designed to guide you through the complexities of device development and regulatory requirements across the globe.

We assist life science leaders in enhancing the technical skills and knowledge of their employees, enabling them to tackle challenges and achieve business objectives. Through a collaborative partnership, we develop and deliver technical training courses that are tailored to your learning requirements and align with your business goals. For further details on how we can support your team, please do not hesitate to get in touch.

The Educo Life Sciences Resource Hub is your premier destination for a plethora of complimentary resources aimed at advancing your career in pharmaceuticals, biotechnology, or medical devices. Explore our exclusive free trainer interviews, insightful articles, and an array of additional resources designed to enhance your professional development.

Regulatory affairs play a vital role in the pharmaceutical and biotechnology sectors, ensuring patient safety at every turn. Established regulations serve to guarantee that all products are both safe and effective for consumer use. Regulatory bodies such as the EMA, MHRA, and HPRA ensure that every product available on the market meets stringent safety and quality standards. Consequently, regulatory requirements affect all departments within a (biopharmaceutical) company, making it essential for professionals to possess a foundational understanding of these regulations.

This course offers a comprehensive insight into the processes involved in obtaining and maintaining market authorisations for medicines within the European Union. Participants will explore the EU legislative framework and the regulatory procedures associated with Marketing Authorisation Applications (MAA). Furthermore, you will examine the regulations that apply throughout the product life cycle, from initial development and submissions to post-market obligations. Upon completion, you will have a thorough understanding of the significance of regulatory affairs within your role and organisation.

With the Educo Post Learning Implementation Plan (PLIP), you will gain a structured approach to applying and integrating the knowledge acquired during the training, facilitating your professional development. Discover more about our classroom and live online training options.

Filing variations are a crucial aspect of regulatory lifecycle management. Optimising your procedures for quicker, streamlined, and compliant variation submissions is essential. Regulators expect to witness successful variations in strategies across regulatory teams. Thus, it is vital to comprehend the regulations, definitions, and best practices for effective implementation.

This training course will offer you a comprehensive overview of the EU regulations concerning variation filings for marketing authorisation. You will explore the different types of variations and learn how to refine your procedures for efficient submission of variations. Additionally, you will examine grouping and work-sharing, ensuring you understand when to apply these concepts to your variations.

Now fully aligned with the latest EU regulatory reforms, this course integrates recent amendments to Commission Regulation (EC) No 1234/2008 — including updates introduced by Commission Regulation (EU) No 712/2012 and Commission Delegated Regulation (EU) 2024/1701 — as well as the new Variations Guidelines that will be mandatory from January 2026. You will acquire clear, practical insights into revised classification rules, mandatory work-sharing, updated submission timelines, and digital filing requirements. This knowledge will empower you to avoid costly delays, mitigate validation risks, and manage EU lifecycle changes with confidence and strategic acumen.

Continuous biomanufacturing holds the potential to enhance product quality, reduce costs, and accelerate time to market. However, there are also challenges that need to be addressed when implementing continuous bioprocessing. These challenges encompass regulatory considerations, the need for adapted technologies, necessary development steps, and thorough validation.

This concise live online training course is designed to help you grasp the fundamentals of adopting a continuous manufacturing approach for unit operations, as well as upstream and downstream processing. Throughout the course, you will explore the regulatory and quality frameworks for continuous bioprocessing to ensure compliance. You will evaluate the key steps required to develop a continuous approach, along with practical guidance for monitoring, controlling, and validating continuous bioprocessing.

Artificial intelligence is revolutionising the way pharmaceutical and biotech organisations discover, develop, and commercialise medicines. Nevertheless, many professionals still find it challenging to implement AI effectively in real-world scenarios.

This course is tailored for R&D, clinical, business, and strategy professionals who wish to progress from merely understanding AI to applying it in practice. It delves into how AI can be utilised throughout the pharmaceutical value chain — encompassing drug discovery, clinical development, due diligence, and strategic decision-making.

Through real-world examples and hands-on exercises, participants will learn to identify high-value use cases, leverage AI tools, and make quicker, more informed decisions.

The establishment and testing of cell banking are vital processes in the development and manufacture of biopharmaceuticals and cell & gene therapy products. Creating a successful Master Cell Bank (MCB) is essential, as it serves as the primary source for deriving Working Cell Banks (WCB). The manufacturing process heavily relies on a consistent supply of viable cells, making it imperative that this process is executed efficiently.

This concise, live online course will equip you with the confidence to manage cell banking for biopharmaceuticals and advanced therapy medicinal products (ATMPs). You will delve into the key regulatory requirements for establishing and testing various cell banks to ensure compliance and maintain quality standards. Upon completion, you will possess the necessary skills to qualify a cell bank system, which includes identity testing, phenotypic and genotypic characterisation, and safety testing.

The course will cover cell banking for biopharmaceuticals, as well as the specific considerations for cell & gene therapies and bioassays. In addition to presentations, participants will have access to practical examples, case studies, and a comprehensive literature review.

The primary aim of conducting comparability studies is to verify that the quality, safety, and efficacy of a drug product are maintained following modifications to the manufacturing process. These studies provide essential connections with the clinical materials used at various stages of the drug development cycle. It is vital to comprehend the product in terms of its mechanism of action, Target Product Profile, and Critical Quality Attributes. The goal is to establish a fingerprint or defined product identity, which can then drive the Analytical Target Profile (ATP) and the overarching control strategy for managing the lifecycle of the product, process, and analytical methods. This approach relies on utilising comparability studies to link different phases of drug development while ensuring continuity of scientific knowledge and understanding.

This course is designed to position comparability studies as an essential tool in the development of biopharmaceutical products. Participants will acquire comprehensive knowledge of advanced process development and quality risk management, as outlined in ICH quality guidelines.

A key focus of the course is to build a robust product and process profile, which enhances process development efforts and facilitates regulatory compliance. This foundation supports comparability studies throughout the product lifecycle, acting as structured milestones that steer each development phase. Participants will learn strategies to adeptly manage the inevitable changes in product and process while minimising potential quality and regulatory risks. Ultimately, the course equips professionals to streamline development, achieving rapid, first-time-right outcomes that fulfil high-quality standards and regulatory expectations.

The quality module of the Common Technical Document (CTD) presents the Chemistry, Manufacturing and Controls (CMC) data within the submission dossier for both small and large molecules. Compiling the CMC regulatory material can be complex; however, completing module 3 with efficiency and accuracy is essential for achieving rapid approval.

This training course explores the regulatory requirements set by the FDA and EMA for both pharmaceuticals and biotechnology. It will equip you with the confidence to identify, compile, and submit the appropriate information in the quality module. Upon completion, you will possess a comprehensive understanding of key areas, including CMC regulatory strategy, constructing the pharmaceutical sections, developing the drug product sections, and creating the Quality Overall Summary (QOS).

The course will also address the anticipated changes to the quality sections of the CTD, such as ICH M4Q(R2) and Module 2.3: Quality Overall Summary, alongside the regulatory factors influencing those changes.

With the Educo Post Learning Implementation Plan (PLIP), you will have a structured framework to apply and implement the knowledge gained during the training, supporting your professional development. Discover more about our classroom and live online training delivery methods.

Distributors and importers are essential in ensuring that medical devices and IVDs on the UK and EU markets comply with regulatory requirements. Under the EU MDR/IVDR and UK MDR regulations, economic operators have well-defined legal responsibilities concerning verification, documentation control, product traceability, complaint management, and post-market surveillance.

This specialised course equips distributors, importers, and own-brand labellers with a comprehensive, practical understanding of their regulatory obligations. Participants will gain insights into verifying conformity, assessing technical documentation, interpreting labelling and certification, and managing compliance throughout the supply chain. The course also delves into the complexities involved in launching products in the markets of Great Britain, Northern Ireland, and the EU, and features a practical workshop using real product documentation and registration databases.

Biosimilars are intricate biological products that necessitate thorough CMC development and robust regulatory strategies to demonstrate their comparability to reference products. Unlike generics, biosimilars require a totality-of-evidence approach, which combines advanced analytics, process control, and clinical evaluation.

This comprehensive two-day course offers an integrated overview of CMC and regulatory strategies for biosimilar development. Participants will gain valuable insights into quality-by-design (QbD) principles, analytical and manufacturing considerations, and global regulatory pathways, including those of the EMA, FDA, WHO, and PMDA. Real-world case studies and examples will shed light on the comparability exercise, clinical evidence requirements, and lifecycle management strategies.

Analytical methods must be validated to ensure the reliability, consistency, and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories conducting the method. Furthermore, when methods are transferred between laboratories, they must be shown to be reliable. In certain circumstances, a waiver for method transfer requirements may be justified. Recent guidance on method validation and transfer has been issued by the FDA and EMA. The USP has provided guidance chapters on method validation, verification, and transfer, equivalence testing, and statistical evaluation. Articles in the US Pharmacopeial Forum have introduced the concepts of measurement uncertainty and lifecycle management for analytical procedures, with new ICH guidance on method development and validation expected soon.

This training course will help you understand the regulatory requirements for method validation, verification, and transfer. It will also suggest strategies to mitigate the risks associated with the method validation process through prior evaluation of method performance and the implementation of effective protocols. The course includes resources to assist you in planning method validation, selecting appropriate acceptance criteria, along with checklists for validation protocols and analytical method contents.

With the Educo Post Learning Implementation Plan (PLIP), you will have the framework necessary to apply and implement the knowledge acquired in the training, supporting your professional development.

The Person Responsible for Regulatory Compliance (PRRC) is a newly established requirement under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). Our comprehensive training programmes for designated PRRCs encompass the specific responsibilities of the role, as well as a wide range of related subjects, including regulatory affairs, quality management, clinical evaluations, technical documentation, labelling, and more. Enhance your understanding of compliance in the medical device sector with our expertly designed courses.

Educo Life Sciences offers an introductory range of short, cost-effective courses designed to deliver a concise yet comprehensive overview of various topic areas. Our courses empower you to gain a solid understanding of subjects including pharmaceutical drug development, cell and gene therapies, biotechnology, and medical devices.

This course will demystify medical devices by clarifying what constitutes a medical device and what does not, as well as explaining how these devices are regulated. We will cover the fundamental requirements for any business involved in the manufacture, import, or distribution of medical devices. Our aim is to assist you in determining whether your product qualifies as a medical device, what steps you need to take to comply with relevant regulations, and what legal obligations you have to uphold product compliance throughout its lifespan in the market.